FTC closes inquiry: offers guidance on filing
Though the FTC concluded that Sanofi-Aventis violated filing requirements of the 2003 Medicare Prescription Drug, Improvement, and Modernization Act (“MMA”), the agency has closed the investigation and offered its reasoning in...To view the full article, register now.
Already a subscriber? Click here to view full article